Drugs / D/C/F/TAF
last change Feb 2014 re-read 2 minutes ago

D/C/F/TAF

Developed for
AIDS
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01565850 Apr 2012 → Jan 2013 AIDS Gilead Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as D/C/F/TAF D/C/F/TAF fixed dose combination (FDC) tablet” NCT01565850